# An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

> **NCT01873729** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 3 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT01873729
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01873729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01873729, "An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01873729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*